Altimmune (ALT) Receivables - Other (2010 - 2026)
Altimmune (ALT) reported Receivables - Other of $1.4 million for Q1 2026, up 250.0% year-over-year from $400000.0 in Q1 2025, and up 27.27% quarter-over-quarter from $1.1 million in Q4 2025.
Altimmune (ALT) Receivables - Other (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 12 years of Receivables - Other data on file, last reported at $1.4 million in Q1 2026.
- Receivables - Other for Q1 2026 came in at $1.4 million, up 250.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 250.0% YoY), and the FY2025 annual result was $1.1 million, up 175.0% from the prior year.
- Receivables - Other improved to $1.4 million in Q1 2026 per ALT's latest filing, from $1.1 million in the prior quarter.
- Over five years, Receivables - Other peaked at $1.4 million in Q1 2026 and troughed at $100000.0 in Q4 2023.
- A 4-year average of $544444.4 and a median of $400000.0 in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 300.0% in 2024, then jumped 100.0% in 2025.
- A 4-year view of Receivables - Other shows it stood at $100000.0 in 2023, then soared by 300.0% to $400000.0 in 2024, then surged by 175.0% to $1.1 million in 2025, then advanced by 27.27% to $1.4 million in 2026.
- Business Quant data shows ALT's Receivables - Other at $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Mar 31, 2017 | 798,855.00 |
| Mar 31, 2017 | 798,855.00 |